Piper Sandler has reiterated its Overweight rating on Aflac and increased its price target from $138 to $143. This revised target suggests a potential upside of 15.3% from the stock's closing price on November 6, 2026, indicating a positive outlook from the analyst firm.
Piper Sandler, a prominent investment bank, has updated its outlook on Aflac, raising its price target to $143 while keeping an Overweight rating. This action signals continued confidence in Aflac's future performance and valuation. For traders, this provides a positive signal, potentially leading to short-term buying interest as the new price target implies a significant upside. Long-term investors might view this as a reaffirmation of their investment thesis. The key opportunity for traders is to capitalize on any immediate positive momentum, while the risk lies in whether the market fully embraces this analyst upgrade or if other factors might overshadow it.